The years 2025 and 2026 mark an unprecedented turning point in the regulation of healthcare products worldwide. Driven by a collective imperative to transition from bureaucratic check-box compliance to proactive, science-based lifecycle oversight, international bodies are fundamentally modifying development pathways. This comprehensive intelligence briefing explores the three structural shifts dictating current global dynamics: the convergence of Artificial Intelligence oversight under legal frameworks like the EU AI Act and FDA Software Lifecycle models; the operational shift from low-cost supply chains to strict regionalized resilience architectures; and the fundamental reorganization of clinical evaluation pathways as exemplified by the United Kingdom's historic 2026 overhaul.
- Quote paper
- Kunal Kunal (Author), 2026, The Paradigm Shift: Paradigm Mutations in Global Pharmaceutical and Medical Device Regulatory Frameworks, Munich, GRIN Verlag, https://www.hausarbeiten.de/document/1771964
